What clinical trials are currently recruiting in New Hampshire?

TrialFinder lists 319 recruiting clinical trials with sites in or near New Hampshire. Results cover a wide range of conditions and are updated regularly from ClinicalTrials.gov.

Do I need insurance to join a clinical trial in New Hampshire?

No. Study-related care is covered by the trial sponsor at no cost to participants. This includes the experimental treatment, required lab tests, and study visits. Many trials also provide compensation for time and travel. Health insurance is not required to search or enroll.

What conditions have clinical trials recruiting in New Hampshire?

Trials in New Hampshire cover a broad range of conditions including cancer, diabetes, heart disease, neurological disorders, autoimmune diseases, mental health conditions, and more. Use TrialFinder to search by specific condition and location.

How do I sign up for a clinical trial in New Hampshire?

Find a trial that matches your condition on TrialFinder, review the eligibility criteria, and contact the research site listed on the trial detail page. Most research teams will conduct a brief phone pre-screening before any in-person visit. You can also create a free TrialFinder profile to get matched to recruiting trials near you.

319 Recruiting Trials

Clinical Trials in New Hampshire

Browse 319 recruiting clinical trials currently enrolling participants in New Hampshire. Search by condition to find trials you may qualify for — at no cost.

Showing 15 of 319 recruiting trials in New Hampshire

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

N/A Athens, Alabama +4 sites · Lumbar Spinal Stenosis

Recruiting

Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

PHASE2 Orange, California +4 sites · Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma

Recruiting

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

PHASE3 Anchorage, Alaska +4 sites · Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8

Recruiting

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

PHASE2 Birmingham, Alabama +4 sites · Extensive Stage Lung Small Cell Carcinoma

Recruiting

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

PHASE2 Anchorage, Alaska +4 sites · Resectable Pancreatic Adenocarcinoma, Pancreatic Acinar Cell Carcinoma

Recruiting

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

PHASE3 Birmingham, Alabama +4 sites · Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

Recruiting

Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors

PHASE1 Tucson, Arizona +4 sites · Advanced Solid Tumor, Advanced Solid Tumors Appropriate for Treatment With Either Nivolumab or Pembrolizumab

Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

PHASE3 Birmingham, Alabama +4 sites · Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8

Recruiting

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

PHASE3 Birmingham, Alabama +4 sites · Neuroblastoma, Ganglioneuroblastoma, Nodular

Recruiting

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

PHASE2 Birmingham, Alabama +4 sites · Acute Myeloid Leukemia

Recruiting

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

PHASE3 Birmingham, Alabama +4 sites · Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features

Recruiting

EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

PHASE3 Huntsville, Alabama +4 sites · Kidney Disease, Chronic

Recruiting

Subcortical Arousal in Perceptual Awareness

NA New Haven, Connecticut +4 sites · Epilepsy

Recruiting

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

PHASE2 Anchorage, Alaska +4 sites · Metastatic Non-small Cell Lung Cancer With MTAP Deletion

Recruiting

Phentermine's Impact on Treatment in Teens

PHASE2 Baton Rouge, Louisiana +4 sites · Childhood Obesity

Recruiting

See all 319 results in New Hampshire

Check Your Eligibility

Create a free profile and our AI will match you to trials in New Hampshire you may qualify for.

Get Matched — Free

No insurance required

Search by Condition in New Hampshire

Diabetes Cancer Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19

Browse Other States

California Texas New York Florida Illinois Pennsylvania Ohio Georgia North Carolina Michigan New Jersey Washington Arizona Massachusetts Tennessee Colorado Minnesota Maryland Wisconsin Oregon